Investment Thesis
Healthcare Triangle exhibits severe financial distress with negative operating cash flow of -9.7M annually against only 1.6M cash reserves, providing less than 2 months of runway. The company is persistently unprofitable with -5.3M operating loss and negative returns on equity (-57%) and assets (-35.9%), indicating unsustainable fundamentals despite reported revenue growth from a minimal base.
Strengths
- Exceptional revenue growth of 1064% YoY demonstrates strong top-line momentum
- Low financial leverage with 0.10x debt-to-equity ratio limits solvency risk
- Current ratio of 2.03x indicates adequate short-term liquidity position
Risks
- Negative operating cash flow of -9.7M annually with only 1.6M cash provides insufficient runway for operations
- Persistent operating losses (-5.3M) and negative net income (-5.0M) with declining profitability margins (-49.7% operating margin)
- Severely negative returns on equity and assets (-57% and -35.9% respectively) indicate systematic shareholder value destruction
- Critical data quality issues with reported gross profit (1.1B) exceeding revenue (10.8M) by 100x raises concerns about financial reporting reliability
Key Metrics to Watch
- Operating cash flow trend - survival depends on achieving positive cash generation
- Cash balance and monthly burn rate - critical monitoring for liquidity crisis
- Operating income and net income path to profitability - must demonstrate breakeven within current cash runway
Financial Metrics
Revenue
10.8M
Net Income
-5.0M
EPS (Diluted)
$-2.23
Free Cash Flow
-9.7M
Total Assets
13.8M
Cash
1.6M
Profitability Ratios
Gross Margin
9,951.6%
Operating Margin
-49.7%
Net Margin
-46.3%
ROE
-57.0%
ROA
-35.9%
FCF Margin
-90.2%
Balance Sheet & Liquidity
Current Ratio
2.03x
Quick Ratio
2.03x
Debt/Equity
0.10x
Debt/Assets
36.9%
Interest Coverage
N/A
Long-term Debt
888.0K
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-11T02:09:27.189402 |
Data as of: 2025-09-30 |
Powered by Claude AI